[Previous] [Table of Contents] [Next]
Changes since the publication of the 2002 Canadian Immunization Guide include the following: 1) no special precaution when administering measles, mumps, and rubella (MMR) vaccine to egg-allergic individuals; 2) information on the new rabies vaccine (RabAvert® ), which is derived from virus grown in chick embryo cell culture; and 3) chicken allergy as a contraindication to vaccination with the yellow fever vaccine.
In this chapter, egg or chicken allergy is defined as an IgE-mediated hyper-sensitivity causing symptoms like, but not limited to, urticaria, swelling of the mouth and throat, difficulty breathing or hypotension. Chicken allergy refers to allergy to chicken meat as opposed to allergy to feathers.
Egg allergy is one of the most common food allergies of childhood, with a prevalence of 1%-3% in children under 3 years of age. As most children outgrow their egg allergy, the prevalence in adulthood is much lower. Isolated chicken allergy is a very rare condition.
Vaccines that contain small quantities of egg protein can cause hypersensitivity reactions in some people with allergies to eggs. The likelihood of such reactions occurring varies considerably among vaccines. The yellow fever vaccines are prepared from virus grown in chick embryos and are the most likely to cause allergic reaction in egg- or chicken-allergic individuals. Allergic reactions can also occur to vaccines against influenza, which are prepared from viruses grown in embryonated eggs. In contrast, the MMR vaccine viruses most widely used in Canada and one of the rabies vaccines (RabAvert® ) are grown in chick embryo cell culture. The final vaccine products may contain trace quantities of egg proteins, but the amount is not felt to be enough to cause an allergic reaction, especially for MMR. Some extra precautions are still recommended for RabAvert®. Egg proteins are not involved in the manufacturing process of the other rabies vaccine (Imovax® Rabies).
MMR vaccine
Anaphylaxis after measles vaccination is rare. It has been reported both in people with anaphylactic hypersensitivity to eggs and in those with no history of egg allergy. In some of these instances it is hypersensitivity to gelatin that is responsible for the anaphylactic reaction. As well, allergy to other components of the vaccine, such as neomycin, has been hypothesized but not proven. The minute quantity of egg proteins contained in the MMR vaccine seems to be insufficient to cause an allergic reaction in egg-allergic people.
Several studies have reported uneventful routine MMR immunization in egg-allergic people and in those with positive MMR skin tests, whereas others have reported occasional adverse reactions despite the use of MMR skin testing and graded challenge vaccination. Therefore the use of skin testing with MMR vaccines in egg-allergic individuals is no longer recommended.
The largest published review of the literature provides data on 1227 egg-allergic patients who received the MMR vaccine as a usual single dose. Only two had any symptoms suggesting an allergic reaction, and they were from the same case report, whereas in better studies no patient reacted. These combined data indicate that 99% of children who are allergic to egg can safely receive the vaccine (95% confidence interval (CI) 99.41%-99.98%).
Four of the best studies from this review of the literature are summarized below.In view of the cumulative data indicating the safety of MMR immunization in people with a history of anaphylactic hypersensitivity to hens' eggs and the lack of evidence of the predictive value of MMR skin testing, the National Advisory Committee on Immunization (NACI) does not recommend routine MMR skin testing or any special precaution in these individuals. As for all vaccines, NACI recommends immunization by personnel with the capability and facilities to manage adverse events following immunization such as anaphylaxis.
Rabies vaccine
Immunization with rabies vaccine obtained by viruses grown in chick embryo cell culture (RabAvert® ) is probably safe in egg-allergic individuals because the vaccine contains only a minute quantity of egg proteins; however, no safety data exist. An alternative vaccine, if available, should be used in egg-allergic individuals. If an alternative vaccine is not available, post-exposure prophylaxis should be administered with strict medical monitoring in facilities where emergency treatment of anaphylaxis is available. For pre-exposure vaccination when no alternative vaccine is available referral to an allergy specialist prior to vaccination is recommended, as vaccination might be possible after careful evaluation, skin testing and graded challenge or desensitization.
Influenza vaccine
Allergic reactions have been reported in patients with egg allergy receiving the influenza vaccine. In the few studies evaluating immunization with influenza vaccine in egg-allergic children, allergic reactions ranged from 0%-40%.
Most influenza vaccines probably contain only a very small amount of egg proteins, but manufacturers do not report the egg content of their influenza vaccine. In some studies in which investigators have determined the egg content of some influenza vaccines, it was found that the egg protein content varied by several logarithmic factors from manufacturer to manufacturer and from year to year.
Egg-allergic individuals should not be routinely vaccinated with the influenza vaccine. Of these individuals, those who are at risk of the complications of influenza should be evaluated by an allergy specialist, as vaccination might be possible after careful evaluation, skin testing and graded challenge or desensitization. If such an evaluation is not possible, the risk of an allergic reaction to the vaccine must be weighed against the risk of influenza disease.
Yellow fever vaccine
The yellow fever vaccine has the greatest likelihood of containing sufficient amounts of egg or chicken proteins to cause an allergic reaction in egg- or chicken-allergic individuals. There have been several reports of anaphylactic reactions to the yellow fever vaccine in egg- or chicken-allergic individuals but no studies have been done in which the vaccine was administered to such individuals in order to monitor for the reaction. The yellow fever vaccine should not be routinely administered to egg- or chicken-allergic individuals. Referral to an allergy specialist is recommended, as vaccination might be possible after careful evaluation, skin testing and graded challenge or desensitization.
Aickin R, Hill D, Kemp A. Measles immunisation in children with allergy to egg. British Medical Journal 1994;309:223-25.
Fasano MB, Wood RA, Cooke SK et al. Egg hypersensitivity and adverse reactions to measles, mumps and rubella vaccine. Journal of Pediatrics 1992;120(6):878-81.
Freigang B, Jadavji TP, Freigang DW. Lack of adverse reactions to measles, mumps and rubella vaccine in egg-allergic children. Annals of Allergy 1994;73:486-88.
Herman JJ, Radin R, Schneiderman R. Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein. Journal of Pediatrics 1983;102(2):196-99.
James JM, Burks AW, Roberson PK et al. Safe administration of the measles vaccine to children allergic to eggs. New England Journal of Medicine 1995;332(19):1262-66.
Kelso JM, Yunginger JW. Immunization of egg-allergic individuals with egg- or chicken-derived vaccines. Immunology and Allergy Clinics of North America 2003;23(4):635-48.
Zeiger RS. Current issues with influenza vaccination in egg allergy. Journal of Allergy and Clinical Immunology 2002;110(6):834-40.
[Previous] [Table of Contents] [Next]
To share this page just click on the social network icon of your choice.